MCK
February 7, 2024 - AI Summary
Undervalued by 52.8% based on the discounted cash flow analysis.
Market cap | $72.24 Billion |
---|---|
Enterprise Value | $73.29 Billion |
Dividend Yield | $2.3971 (0.43%) |
Earnings per Share | $22.39 |
Beta | -0.03 |
Outstanding Shares | 129,985,514 |
Avg 30 Day Volume | 791,807 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 24.06 |
---|---|
PEG | 4734.63 |
Price to Sales | 0.24 |
Price to Book Ratio | -35.28 |
Enterprise Value to Revenue | 0.24 |
Enterprise Value to EBIT | 17.55 |
Enterprise Value to Net Income | 24 |
Total Debt to Enterprise | 0.08 |
Debt to Equity | -2.86 |
No data
No data
McKesson Corporation is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions. McKesson partners with pharmaceutical manufacturers, p...